Die US-Notenbank hat ihren Spielraum ausgereizt und den Leitzins um 50 Basispunkte gesenkt. Es ist die erste Leitzinssenkung seit mehr…
Goldman Sachs stuft Merck mit "Buy" ein.…
The FDA approves MRKs Keytruda for first-line treatment of malignant pleural mesothelioma. This marks Keytrudas first approval for the given…
…
MRK and Daiichi Sankyos patritumab deruxtecan shows statistically significant progression-free survival improvement in previously treated EGFR-mutated NSCLC.…
Die
Merck-Aktie (ISIN: DE0006599905) prallte in den vergangenen Monaten bereits zwei
mal von ihrem Jahreshoch im Bereich von 177 Euro nach unten…
Zum Wochenstart hat sich der deutsche Aktienmarkt eine kleine Verschnaufpause gegönnt und 0,35 Prozent an Wert abgeben müssen. Der Dienstag…
NCNA stock surges 151% on positive efficacy data from the mid-stage melanoma study of NUC-7738 in combination with Mercks Keytruda.…
Siemens und der Pharmakonzern intensivieren ihre Zusammenarbeit im Bereich der modularen Produktion. +++ Alles Entwicklungen zu Siemens im Newsblog. +++…
Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the…
…
…
The company is adding onto its success outperforming Mercks top drug in lung cancer patients.…
Wien (www.aktiencheck.de) - Merck-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), erhöht das…
Merck, ein führendes Wissenschafts- und Technologieunternehmen, hat den ersten skalierbaren Einweg-Mischer speziell für die Herstellung von Antikörper-Wirkstoff-Konjugaten (ADCs) auf den…
Data from a late-stage study shows that SMMTs experimental antibody beat Keytruda in a head-to-head setting in treating certain patients…
Mercks Keytruda is the standard of care for NSCLC. Ivonescimab, however, shows clinically meaningful benefit over Keytruda in a phase…
Its that time of day again, the final trading hour of Monday, September 9. Market Domination hosts Julie Hyman and…
The companys new lung cancer treatment could unseat Mercks Keytruda in the $50 billion-plus lung cancer treatment market.…
The companys new lung cancer treatment could unseat Mercks Keytruda in the $50 billion-plus lung cancer treatment market.…
U.S. equities rallied back from last weeks selloff at midday as investors put more money into blue chip stocks.…
These are the stocks posting the largest moves in the premarket.…
…
…
Am deutschen Aktienmarkt ist die Aktie von Merck gegenwärtig unauffällig. Der jüngste Kurs betrug 170,25 Euro. Die Wertschätzung der Börsenteilnehmer…
The Global Hematologic Malignancies Market Size was Valued at USD 67.18 Billion in 2023 and the Worldwide Hematologic Malignancies Market…
Merck (MRK) closed the most recent trading day at $117.84, moving -0.63% from the previous trading session.…
European Commission approves expanded use of Mercks Keytruda in bladder cancer. Sanofi & Lilly announce data from phase III studies…
Is the healthcare stock an underrated buy right now?…
Is the healthcare stock an underrated buy right now?…
MRKs Keytruda gets approval in combination with Astellas and Pfizers Padcev for treating first-line advanced urothelial carcinoma.…
Data from an early-stage study shows that PCVXs pneumococcal vaccine has achieved immune responses rivaling vaccines marketed by Pfizer and…
…
FLORHAM PARK, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a…
…
The global biotechnology sector is on track to become a multi-trillion dollar industry. Worldwide, the biotech space is worth an…
Merck has stopped two separate late-stage studies of its immunotherapy Keytruda in patients with skin and lung cancers, the company…
Merck begins the second phase III study on its LSD1 inhibitor, bomedemstat, for treating certain patients with essential thrombocythemia, a…
MRKs Winrevair becomes the first novel activin signaling inhibitor therapy approved in Europe to treat PAH.…
…
Todays Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), Merck & Co., Inc.…
Declining estimates and the recent price drop make investors skeptical about holding Mercks (MRK) stock.…
Aktuelle Kursentwicklung Am heutigen Handelstag legte die Merck-Aktie im XETRA-Handel ab 15:53 Uhr um 0,6 Prozent zu und notierte bei…
Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…
Der Kurs der dem Anteilsschein von Merck, inc kommt kaum von der Stelle. Zuletzt zahlten Investoren für das Papier 113,14…
Merck (MRK) signs a new collaboration with a private drugmaker. AstraZeneca (AZN) gets approvals for expanded use of Imfinzi.…
Merck stock is down 11% in the last three months and could potentially be headed for new lows.…
…
Darmstadt (www.aktiencheck.de) - Welche Kursziele und Ratings trauen die Analysten der führenden Banken und Research-Häuser der Merck-Aktie (ISIN: DE0006599905, WKN:…
Merck (MRK) to acquire worldwide rights to a novel investigational clinical-stage bispecific antibody for treating B-cell-associated diseases. The deal is…